Overview
Manali Bhave is an Oncologist in Atlanta, Georgia. Dr. Bhave has been practicing medicine for over 15 years and is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast.
Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1365 Clifton Road Northeast, BldgC, Atlanta, GA 30322
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Emory Winship Cancer Institute
Kevin Kalinsky is an Oncologist in Atlanta, Georgia. Dr. Kalinsky is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.
Emory Winship Cancer Institute
Keerthi Gogineni is an Oncologist in Atlanta, Georgia. Dr. Gogineni has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Tissue Biopsy.
Emory Winship Cancer Institute
Jane Meisel is an Oncologist in Atlanta, Georgia. Dr. Meisel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, and Ovarian Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Bhave isDistinguished. Learn about Breast Cancer.
- Advanced
- AngiosarcomaDr. Bhave isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Bhave isAdvanced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Bhave isAdvanced. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Bhave isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AgranulocytosisDr. Bhave isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Bhave isExperienced. Learn about EGFR Positive Lung Cancer.
- HER-2 Positive Breast CancerDr. Bhave isExperienced. Learn about HER-2 Positive Breast Cancer.
- Large-Cell Lung CarcinomaDr. Bhave isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Bhave isExperienced. Learn about Lung Adenocarcinoma.